Several studies have pointed to the level of myeloid cell and T-cell infiltration in GBM, the ratios of effector CD8+ T cells: Treg and the level of immune checkpoint molecule expression on intra-tumoural and circulating T cells and myeloid cells. This evidence concerns the gene CD8A and neoplasm.